 |
 |
 |
           |
 |
 |
 |
|
 |
 |
|
|
|
 |
Orphan Drugs: Hope Where There Is Little or No Hope
NEW YORK, N.Y., February 18, 2004 - On a visit to his doctor, Gary Jacob received distressing news - not about himself, but a friend of the doctor's. While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis - he had a disease known as multiple myeloma, a bone marrow blood cancer. The diagnosis was nothing less than a death sentence. Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive. Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients. "The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients." In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline. Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process. The program covers drugs for orphan diseases with patient populations under 200,000. The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases. Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases. Large drug-makers have been largely missing from the efforts. According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies. The reason: expectations of unfavorable investment returns. The FDA orphan drug incentives - grants, seven years of marketing exclusivity and tax breaks - have drawn small pharmaceutical companies with promising drug candidates into the breach. While the future is brighter, the task is still daunting to develop drugs for orphan diseases. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients. Some diseases affect fewer than 100 patients, according to the National Institutes of Health. An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available. Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma. "He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. " Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School. The Phase I/IIa trials for Atiprimod are slated to begin later this month. Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising. "In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways - by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker. About The Author Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets.
MORE RESOURCES:
Medicine - Google News |
|
|
|
RELATED ARTICLES
Risperdal Side Effects: Neuroleptic Malignant Syndrome NMS Risperdal is an atypical anti-psychotic drug that balances the levels of dopamine and serotonin in the brain. It helps to stabilize patients with mental illness including the manic stages of bipolar disorder and schizophrenia. NIH Official Altered Drug Study NIH Official Altered Drug StudyDr. Edmund Tramont, director of the National Institute of Allergy and Infectious Disease Division of AIDS, altered the conclusions from a safety report on pregnant women taking the drug nevirapine in order to cover up its negative side effects. Online Pharmacies and the FDA The FDA (Food and Drug Administration) is responsible for overseeing the testing, manufacturing, and distribution of prescription drugs in the United States.Drug companies in the United States operate in a free market and can charge whatever they want for their medications. Ativan Side Effects Lawyer The drug Lorazepan is marketed under the names Alzapam, Ativan, Loraz, Lorazepam, Intensol. Ativan is the safest form of this type of drug because it has less of an effect on the liver than other benzodiazepines, which means that a patient can take it in conjunction with other liver affecting medications like birth control pills, anti-abuse drugs, propranolol, and ulcer medications. Aleve, Vioxx, Celebrex, and Bextra: What You Need To Know About Arthritis Pain Medications Recent controversy about the safety of pain medications for arthritis has left patients and health care professionals alike confused about which medications are safe to use. In fact, a recent survey by the Boston-based Rippe Lifestyle Institute indicated that many people with arthritis are suffering unnecessarily because they have stopped or reduced their use of pain relievers due to confusion about which drugs are considered safe. Study Confirms IBS Improvement Irritable bowel syndrome is a debilitating and distressing condition, which affects 10-20% of the population. IBS is characterized by abdominal pain and altered bowel function such as constipation, diarrhea or alternating diarrhea and constipation. How To Medically Treat Nail Fungus Warning: This article is for information only and can not be used to supplement your doctor's advice. You should contact your doctor for nail fungus treatment. Medical Tourism Opportunities in India More and more people have started travelling to India for Medical Treatment and during the past year alone, over 150000 people travelled to India for their medical requirements. Medical Tourism is finally coming of age. Is Anxiety Ruling Your Life? Anxiety is the most frequently occurring mental health disorder in the United States, according to the US Surgeon General. There are millions of people who are diagnosed with it every year. Cut Your Prescription Drug Costs Without Having to Buy Foreign Drugs Save Up to 93% by Asking for a Generic - Use generics whenever they are available. Both brand name and generic drugs contain the same active ingredients, are the same in strength and dosage and meet the same government quality control standards. Traditional Treatments for Back Pain... Which Ones Work and Which Ones Don't? When Dorothy followed the yellow brick road, she was told to do so by those who wanted her to get where she wanted go. Well as humans when we blindly follow recommendations even by individuals who have good intentions, it may not always be your best option. Amazing Shoulder Pain Reversing Secrets! Whether you're a weekend athlete, or a gardener that overdid it, or a person with arthritis, there's hope for you. According to Dr. Antibiotics and Bowel Flora The word Antibiotic is constructed from Greek words anti, which means "against" and bios, meaning "life", is a phrase used to describe an antibacterial substance made from micro-organisms, all though nowadays most are made synthetically. Antibiotics inhibit the growth or destroy other micro-organisms; penicillin, cephalosporin, amino-glycosides, streptomycin and tetracycline are all examples of common antibiotics. A Guide to Arthritis Pain Relief In a recent survey on pain conducted by the Stanford University Medical Center, arthritis pain was cited as the chief complaint among America's seniors, with thirty-two percent of the senior population listing arthritis as the specific cause of their suffering. Arthritis does strike children and young adults as well, although it afflicts the mature segment of the population more frequently. Back Pain & Muscle Pain - Effective & Natural Pain Treatment Alternatives Pain and Stress. They seem almost to go hand in hand - not only in their negative connotation, but also in their biological causes and triggers. Stem Cell Research How To Buy Your Way Out Of An Early Death From An Incurable Disease.How?. Are You Suffering From Addiction? Many researchers believe that addiction is a behavior that can be controlled to some extent and also a brain disease. And since some testing with functional magnetic resonance imaging (FMRI) found that all addictions tend to cause nearly the same reactions inside the brain, there could be one type of control model for addiction health-related issues. Utah Drug Rehab: Searching For A Therapist Finding the right treatment for any person suffering with a drug abuse problem can be a difficult task - where do you start, how do you know what to look for, how do I find a good therapist or treatment center in my area? Thankfully, there are many resources to help you find the help that you or a loved one need - here are some tips to help you locate Utah drug rehab help.There are many online directories that compile records of qualified therapists and centers nationwide, and you can use these to find Utah drug rehab help by simply entering your particular location into their search engines. What is Bextra? (FDA Recalled Drug) Bextra, also known as valdecoxib, is a prescribed medication used to alleviate the problems associated with arthritis and other inflammation-related conditions. The drug helps reduce the pain of swelling and fever without causing stomach irritation like aspirin. Watch Out for Misleading Pharmaceutical Advertising In 1997, the Food and Drug Administration relaxed the rules for drug advertising on television and radio. Since that time, the airwaves have been flooded with commercials for all sorts of drugs.
|
 |